🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4270 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,45

Volumen hoy

2.420.374

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 9 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/03/2019 38,64 39,43 38,27 39,42 +2,07% 3,00% 344.400
15/03/2019 39,50 40,13 38,52 38,62 -1,71% 4,08% 512.100
14/03/2019 38,61 39,84 38,61 39,29 +1,45% 3,19% 348.300
13/03/2019 37,58 38,85 37,38 38,73 +3,03% 3,91% 607.500
12/03/2019 37,75 38,17 37,27 37,59 -0,50% 2,38% 490.400
11/03/2019 37,07 38,48 36,66 37,78 +3,59% 4,91% 461.200
08/03/2019 36,28 36,56 35,07 36,47 -0,68% 4,11% 731.900
07/03/2019 37,41 37,41 36,15 36,72 -1,66% 3,37% 654.800
06/03/2019 39,16 39,23 37,17 37,34 -4,45% 5,26% 817.700
05/03/2019 39,95 40,51 38,07 39,08 -4,12% 6,11% 905.700
04/03/2019 42,28 42,58 39,93 40,76 -3,34% 6,27% 734.200
01/03/2019 41,26 42,29 37,89 42,17 +2,40% 10,66% 1.335.300
28/02/2019 44,00 45,42 40,49 41,18 +1,35% 11,20% 1.834.700
27/02/2019 40,42 41,24 40,03 40,63 +0,59% 2,99% 731.100
26/02/2019 39,48 40,53 39,07 40,39 +2,25% 3,70% 438.100
25/02/2019 39,83 40,43 39,29 39,50 -0,53% 2,86% 362.000
22/02/2019 39,70 40,38 39,28 39,71 +0,25% 2,77% 291.300
21/02/2019 40,25 40,59 39,01 39,61 -1,59% 3,93% 463.300
20/02/2019 39,98 40,33 39,19 40,25 +0,78% 2,85% 494.200
19/02/2019 40,48 41,14 39,90 39,94 -1,82% 3,06% 621.000
15/02/2019 39,76 40,95 39,37 40,68 +2,52% 3,97% 478.500
14/02/2019 37,97 40,18 37,88 39,68 +4,78% 6,06% 950.600
13/02/2019 37,95 38,45 37,07 37,87 +0,00% 3,64% 1.482.400
12/02/2019 37,77 38,34 37,09 37,87 +0,26% 3,31% 1.208.700
11/02/2019 37,43 37,80 37,04 37,77 +0,51% 2,03% 361.000
08/02/2019 37,46 37,82 37,15 37,58 +0,29% 1,79% 432.800
07/02/2019 38,25 38,42 37,16 37,47 -2,93% 3,29% 499.400
06/02/2019 39,15 39,74 38,08 38,60 -1,40% 4,24% 412.500
05/02/2019 40,18 40,60 39,07 39,15 -2,32% 3,81% 508.600
04/02/2019 39,34 40,42 39,17 40,08 +2,09% 3,18% 307.900